2 unknown, 1 completed. 2 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Mumps Vaccine: new trials by email Literature Review of Mumps Vaccine trials Research Report on Mumps Vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Immunogenicity and Safety of the Booster Doses of a Live-attenuated Mumps Vaccine in Junior High School Students Mumps vaccine, Live (MV), Influenza Vaccine, inactivated, quadrivlent(QIV) - Mumps, Influenza | Phase 4 | Unknown | Sinovac Biotech Co., Ltd | 400 | 2023-11-04 | 2024-01-17 |
| Clinical Trial to Evaluate the Safety and Immunogenicity of Mumps Vaccine Mumps vaccine, measles, mumps and rubella combined vaccine, live - Mumps | Phase 4 | Completed | Sinovac (Dalian) Vaccine Technology Co., Ltd. | 920 | 2020-11-18 | 2021-08-18 |
| Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants ≥3.0 lgCCID50/mlbut <3.5lgCCID50/ml Live Attenuated Mumps Vaccine (Human Diploid Cell) in infants(8-24 months old), ≥4.5 lgCCID50/ml Live Attenuated Mumps Vaccine (Human Diploid Cell) in infants(8-24 months old), Measles and Mumps Combined Vaccine，Live(SIBP)( positive control) - Epidemic Parotitis,Mumps | Phase 2 | Unknown | Institute of Medical Biology, Chinese Academy of Medical Sciences | 1080 | 2017-05-20 | 2023-10-10 |
Mumps (3) · Influenza, Human (1) · Measles (1)
Institute of Medical Biology, Chinese Academy of Medical Sciences (1) · Sinovac (Dalian) Vaccine Technology Co., Ltd. (1) · Sinovac Biotech Co., Ltd (1)
China (3)
Beifang Yang, PhD (1) · Lirong Huang, Bachelor (1) · Weijun Hu, Master (1)